AileenCleary(Cleary)CohenMD

PubMed

• 78 citations
  Zanubrutinib or Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia.
  Jennifer R Brown, Barbara Eichhorst, Peter Hillmen, Wojciech Jurczak, Maciej Kaźmierczak, Nicole Lamanna, Susan M O'Brien, Constantine S Tam, Lugui Qiu, Keshu Zhou, Ma...> ;The New England Journal of Medicine. 2023 Jan 26
• 19 citations
  Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single...
  Mazyar Shadman, Ian W Flinn, Moshe Y Levy, Ryan F Porter, John M Burke, Syed F Zafar, Jamal Misleh, Edwin C Kingsley, Habte A Yimer, Benjamin Freeman, Subramanya S Rao...> ;The Lancet. Haematology. 2023 Jan 1
• 60 citations
  Zanubrutinib versus bendamustine and rituximab in untreated chronic lymphocytic leukaemia and small lymphocytic lymphoma (SEQUOIA): a randomised, controlled, phase 3 t...
  Constantine S Tam, Jennifer R Brown, Brad S Kahl, Paolo Ghia, Krzysztof Giannopoulos, Wojciech Jurczak, Martin Šimkovič, Mazyar Shadman, Anders Österborg, Luca Laurent...> ;The Lancet. Oncology. 2022 Aug 1
• 63 citations
  Zanubrutinib monotherapy for patients with treatment-naïve chronic lymphocytic leukemia and 17p deletion
  Constantine S. Tam, Tadeusz Robak, Paolo Ghia, Brad S. Kahl, Patricia F. Walker, Wojciech Janowski, David Simpson, Mazyar Shadman, Peter Ganly, Luca Laurenti, Stephen ...> ;Haematologica. 2020 Oct 13
• 43 citations
  ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.
  Peter Hillmen, Jennifer R. Brown, Barbara Eichhorst, Nicole Lamanna, S. M. O'Brien, Lugui Qiu, Tommi Salmi, James Hilger, Kenneth Wu, Aileen Cohen, Jane Huang, Constan...> ;Future Oncology. 2020 Mar 24
• Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
  Kornblau, S. M.,Cohen, A. C.,Soper, D.,Huang, Y. W.,Cesano, A.> ;Cytometry B Clin Cytom. 2013 Oct 10
• Age-related changes of healthy bone marrow cell signaling in response to growth factors provide insight into low risk MDS.
  Kornblau, S. M.,Cohen, A. C.,Soper, D.,Huang, Y. W.,Cesano, A.> ;Cytometry B Clin Cytom. 2013 Aug 20
• 15 citations
  Development and validation of a single‐cell network profiling assay‐based classifier to predict response to induction therapy in paediatric patients with de novo acute...
  Norman J. Lacayo, Todd A. Alonzo, Urte Gayko, David B. Rosen, Matt Westfall, Norman Purvis, Santosh Putta, Brent Louie, James Hackett, Aileen Cohen, Alessandra Cesano,...> ;British Journal of Haematology. 2013 Jul 1
• 5 citations
  Functional Pathway Analysis Using SCNP of FLT3 Receptor Pathway Deregulation in AML Provides Prognostic Information Independent from Mutational Status
  Alessandra Cesano, Santosh Putta, David B. Rosen, Aileen Cohen, Urte Gayko, Kavita Mathi, John Woronicz, Rachael E. Hawtin, Larry D. Cripe, Zhuoxin Sun, Martin S. Tall...> ;Plos One. 2013 Feb 19
• 280 citations
  Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries
  Ludovic de Beaucoudrey, Arina Samarina, Jacinta Bustamante, Aurélie Cobat, Stéphanie Boisson-Dupuis, Jacqueline Feinberg, Saleh Al-Muhsen, Lucile Janniere, Yoann Rose,...> ;Medicine. 2010 Nov 1
• 173 citations
  Cutting Edge: Decreased Accumulation and Regulatory Function of CD4+CD25high T Cells in Human STAT5b Deficiency
  Aileen C. Cohen, Kari C. Nadeau, Wenwei Tu, Vivian Hwa, Kira Y. Dionis, Liliana Bezrodnik, Alejandro Teper, María Isabel Gaillard, Juan J. Heinrich, Alan M. Krensky, R...> ;Journal of Immunology. 2006 Sep 1
• 44 citations
  Impaired allogeneic activation and T-helper 1 differentiation of human cord blood naive CD4 T cells.
  Li Chen, Aileen C. Cohen, David B. Lewis> ;Biology of Blood and Marrow Transplantation. 2006 Feb 1
• Join now to see all